Analyst Research: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

71.27USD
12 Feb 2016
Change (% chg)

$-0.15 (-0.21%)
Prev Close
$71.42
Open
$71.57
Day's High
$71.72
Day's Low
$70.44
Volume
1,963,504
Avg. Vol
1,460,270
52-wk High
$92.83
52-wk Low
$68.32

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Trading Report for (LLY). A detailed report, including free correlated market analysis, and updates. 12 Feb 2016 Stock Traders Daily 12 20.00
Our Economy without Stimulus; forward observations. 12 Feb 2016 Stock Traders Daily 102 20.00
Thomson Reuters Stock Report - Eli Lilly and Co (LLY-N) 12 Feb 2016 Thomson Reuters Stock Report 12 25.00
LLY: Due Diligence Review: Forensic Earnings and Valuation 11 Feb 2016 New Constructs, LLC 10 25.00
Eli Lilly & Company 9 Feb 2016 Acquisdata 20 15.00
Company Snapshot - Lilly Eli & Co 8 Feb 2016 Directors Deals Ltd. 1 12.00
Wright Investors Service Comprehensive Report for Eli Lilly and Company 7 Feb 2016 Wright Reports 55 75.00
LLY.N - Event Brief of Eli Lilly and Co conference call, Jan. 28, 2016 / 9:00AM ET 28 Jan 2016 Thomson Reuters StreetEvents 27 75.00
LLY.N - Event Transcript of Eli Lilly and Co conference call, Jan. 28, 2016 / 9:00AM ET 28 Jan 2016 Thomson Reuters StreetEvents 27 75.00
 
Name Age Since Current Position

John Lechleiter

61 2013 Chairman of the Board, President, Chief Executive Officer

Derica Rice

50 2013 Chief Financial Officer, Executive Vice President - Global Services

Maria Crowe

55 2012 President - Manufacturing Operations

Jan Lundberg

61 2010 Executive Vice President - Science and Technology, President - Lilly Research Laboratories

Melissa Barnes

46 2013 Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer
Search Stocks